Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/GH

GH

Guardant Health, Inc.

Healthcare - US

Guardant Health, Inc. is a precision oncology company specializing in blood and tissue-based diagnostic tests, real-world data sets, and AI-driven analytics to enhance cancer detection, treatment, and patient care. Founded in 2012 and headq…

HQ: Palo Alto, CA, United States of Americaguardanthealth.com

USD157.38-1.04%vs prev. close

Market snapshot

Price

USD157.38

Daily move

-1.04%

P/E

—

EPS TTM

-3.51

Dividend yield

—

Beta

1.58

Market cap

21.1B

Price history

GH price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Guardant Health	GH	Diagnostics & Research	21.1	—	—	-2.5%	-4.7%	+19.6%	+84.1%	+177.1%	+54.1%

Subscribe to Equity Analytics to compare GH with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.